|Day's Range||0.4000 - 0.4000|
DULUTH, Ga., Feb. 10, 2020 -- National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its fourth quarter 2019 financial results before the.
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
National Vision Holdings, Inc. (NASDAQ:EYE), which is in the specialty retail business, and is based in United States...
Privé Revaux, the affordable celebrity eyewear brand that exploded onto the scene two years ago, is continuing its massive retail expansion and exclusive optical partnership with America's Best Contacts & Eyeglasses, part of National Vision Holdings, Inc. (NASDAQ: EYE), one of the nation's largest optical retailers providing quality, affordable eye care and eyewear. After an extremely successful pilot program at select America's Best locations, Privé Revaux is now available at all brand locations nationwide.
Hologic (HOLX) expects to witness favorable outcomes from the sell-off of the Cynosure medical aesthetics business, which was its loss-making arm since 2017.
Thermo Fisher Scientific (TMO) recently unveils a product suite comprising the TSQ Altis, Quantis MD mass spectrometers and Vanquish MD HPLC.
Masimo (MASI) will cater to the whole prenatal patient population, with the recent FDA clearance within the SET pulse oximetry business.
Edwards Lifesciences' (EW) HemoSphere all-in-one monitoring platform is gaining momentum on the back of a strong rollout that sees a full-market launch.
Intersect ENT (XENT) recently closes its ENCORE study, a small 50-patient open label program designed to evaluate the safety of the repetitive use of SINUVA.
Neogen Corporation (NEOG) disappoints investors with dismal second-quarter fiscal 2020 results. However, the Food Safety segment showcased a robust performance.
NuVasive (NUVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zimmer Biomet (ZBH) is executing well within its priority areas like quality remediation, supply recovery efforts and product rollouts.
Medtronic (MDT) strengthens its robotics platform with the receipt of regulatory approval and the subsequent upgradation of its enabling technology portfolio.
Globus Medical's (GMED) U.S. Spine business is securing a market share on the back of competitive representative recruiting and an implant pull-through from ExcelsiusGPS installations.
If you're interested in National Vision Holdings, Inc. (NASDAQ:EYE), then you might want to consider its beta (a...